INDUSTRY OVERVIEW
The Organs-on-chips is Growing at 30% and is expected to reach 5Billion by 2030. Below mentioned are some of the dynamics shaping the Organs-on-chips .Organs-on-chips Market Size in (USD Billion) CAGR Growth Rate 30%
| Study Period | 2024-2030 |
| Market Size (2019): | 1.5Billion |
| Market Size (2030): | 5Billion |
| CAGR (2019 - 2030): | 30% |
| Fastest Growing Region | North America |
| Dominating Region | Europe |
www.htfmarketinsights.com
Lab models that mimic human organs using microfluidic systems for testing drugs, researching diseases, and understanding human physiology.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Expansion Of Drug Testing And Development
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Ethical Concerns
- High Development Costs
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Use of AI to enhance predictive accuracy
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Expansion Of Drug Testing And Development
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Microfluidic Systems
Segmentation by Application
- Biomedical Research
- Drug Development
- Disease Modeling
Organs-on-chips Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The Europe currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, North America is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
North America
Dominating Region
Europe
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Emulate
- TissUse
- AxoGen
- CN Bio Innovations
- Organovo
- Mimetas
- 3D Biotek
- StemoniX
- MIMETAS
- Nortis
- Biowire
- Hesperos
- 8D Technologies
- Pioneering Technology
- Prellis Biologics
- Ncardia
- Synlogic
- BioTissue
- InSphero
Organs-on-chips Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2019 |
|
Based Year Market Size (2023) |
1.5Billion |
|
Historical Period |
2024 to 2019 |
|
CAGR (2019 to 2030) |
30% |
|
Forecast Period |
2019 to 2030 |
|
Forecasted Period Market Size (2030) |
5Billion |
|
Scope of the Report |
Segmentation by Type Microfluidic Systems, Segmentation by Application Biomedical Research, Drug Development, Disease Modeling, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Emulate, TissUse, AxoGen, CN Bio Innovations, Organovo, Mimetas, 3D Biotek, StemoniX, MIMETAS, Nortis, Biowire, Hesperos, 8D Technologies, Pioneering Technology, Prellis Biologics, Ncardia, Synlogic, BioTissue, InSphero |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Organs-on-chips - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Organs-on-chips Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Organs-on-chips Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Organs-on-chips Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Expansion of drug testing and development
-
3.2 Available Opportunities
- 3.2.1 Expansion of drug testing and development
- 3.2.2 Opportunities in personalized healthcare solutions
-
3.3 Influencing Trends
- 3.3.1 Use of AI to enhance predictive accuracy
- 3.3.2 Integration with other research technologies like CRISPR
-
3.4 Challenges
- 3.4.1 Ethical concerns
- 3.4.2 High development costs
- 3.4.3 Need for industry standardization
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Organs-on-chips Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Organs-on-chips Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Organs-on-chips : Competition Benchmarking & Performance Evaluation
- 5.1 Global Organs-on-chips Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Organs-on-chips Revenue 2019
- 5.3 Global Organs-on-chips Sales Volume by Manufacturers (2019)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Strategic Group Analysis
- 5.6 5C’s Analysis
Chapter 6: Global Organs-on-chips Market: Company Profiles
- 6.1 Emulate
- 6.1.1 Emulate Company Overview
- 6.1.2 Emulate Product/Service Portfolio & Specifications
- 6.1.3 Emulate Key Financial Metrics
- 6.1.4 Emulate SWOT Analysis
- 6.1.5 Emulate Development Activities
- 6.2 TissUse
- 6.3 AxoGen
- 6.4 CN Bio Innovations
- 6.5 Organovo
- 6.6 Mimetas
- 6.7 3D Biotek
- 6.8 StemoniX
- 6.9 MIMETAS
- 6.10 Nortis
- 6.11 Biowire
- 6.12 Hesperos
- 6.13 8D Technologies
- 6.14 Pioneering Technology
- 6.15 Prellis Biologics
- 6.16 Ncardia
- 6.17 Synlogic
- 6.18 BioTissue
- 6.19 InSphero
- 6.20 GlycoBio
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Organs-on-chips by Type & Application (2024-2030)
-
7.1 Global Organs-on-chips Market Revenue Analysis (USD Million) by Type (2024-2019)
- 7.1.1 Microfluidic Systems
- 7.1.2 Lab-on-a-chip
-
7.2 Global Organs-on-chips Market Revenue Analysis (USD Million) by Application (2024-2019)
- 7.2.1 Biomedical Research
- 7.2.2 Drug Development
- 7.2.3 Disease Modeling
- 7.3 Global Organs-on-chips Market Revenue Analysis (USD Million) by Type (2019-2030)
- 7.4 Global Organs-on-chips Market Revenue Analysis (USD Million) by Application (2019-2030)
Chapter 8 : North America Organs-on-chips Market Breakdown by Country, Type & Application
- 8.1 North America Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 8.2.1 Microfluidic Systems
- 8.2.2 Lab-on-a-chip
-
8.3 North America Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 8.3.1 Biomedical Research
- 8.3.2 Drug Development
- 8.3.3 Disease Modeling
- 8.4 North America Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 8.5 North America Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 8.6 North America Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Organs-on-chips Market Breakdown by Country, Type & Application
- 9.1 LATAM Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 9.2.1 Microfluidic Systems
- 9.2.2 Lab-on-a-chip
-
9.3 LATAM Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 9.3.1 Biomedical Research
- 9.3.2 Drug Development
- 9.3.3 Disease Modeling
- 9.4 LATAM Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 9.5 LATAM Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 9.6 LATAM Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 10 : West Europe Organs-on-chips Market Breakdown by Country, Type & Application
- 10.1 West Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 10.2.1 Microfluidic Systems
- 10.2.2 Lab-on-a-chip
-
10.3 West Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 10.3.1 Biomedical Research
- 10.3.2 Drug Development
- 10.3.3 Disease Modeling
- 10.4 West Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 10.5 West Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 10.6 West Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 11 : Central & Eastern Europe Organs-on-chips Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 11.2.1 Microfluidic Systems
- 11.2.2 Lab-on-a-chip
-
11.3 Central & Eastern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 11.3.1 Biomedical Research
- 11.3.2 Drug Development
- 11.3.3 Disease Modeling
- 11.4 Central & Eastern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 11.5 Central & Eastern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 11.6 Central & Eastern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 12 : Northern Europe Organs-on-chips Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 12.2.1 Microfluidic Systems
- 12.2.2 Lab-on-a-chip
-
12.3 Northern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 12.3.1 Biomedical Research
- 12.3.2 Drug Development
- 12.3.3 Disease Modeling
- 12.4 Northern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 12.5 Northern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 12.6 Northern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 13 : Southern Europe Organs-on-chips Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 13.2.1 Microfluidic Systems
- 13.2.2 Lab-on-a-chip
-
13.3 Southern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 13.3.1 Biomedical Research
- 13.3.2 Drug Development
- 13.3.3 Disease Modeling
- 13.4 Southern Europe Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 13.5 Southern Europe Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 13.6 Southern Europe Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 14 : East Asia Organs-on-chips Market Breakdown by Country, Type & Application
- 14.1 East Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 14.2.1 Microfluidic Systems
- 14.2.2 Lab-on-a-chip
-
14.3 East Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 14.3.1 Biomedical Research
- 14.3.2 Drug Development
- 14.3.3 Disease Modeling
- 14.4 East Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 14.5 East Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 14.6 East Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 15 : Southeast Asia Organs-on-chips Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 15.2.1 Microfluidic Systems
- 15.2.2 Lab-on-a-chip
-
15.3 Southeast Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 15.3.1 Biomedical Research
- 15.3.2 Drug Development
- 15.3.3 Disease Modeling
- 15.4 Southeast Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 15.5 Southeast Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 15.6 Southeast Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 16 : South Asia Organs-on-chips Market Breakdown by Country, Type & Application
- 16.1 South Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 16.2.1 Microfluidic Systems
- 16.2.2 Lab-on-a-chip
-
16.3 South Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 16.3.1 Biomedical Research
- 16.3.2 Drug Development
- 16.3.3 Disease Modeling
- 16.4 South Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 16.5 South Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 16.6 South Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 17 : Central Asia Organs-on-chips Market Breakdown by Country, Type & Application
- 17.1 Central Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 17.2.1 Microfluidic Systems
- 17.2.2 Lab-on-a-chip
-
17.3 Central Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 17.3.1 Biomedical Research
- 17.3.2 Drug Development
- 17.3.3 Disease Modeling
- 17.4 Central Asia Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 17.5 Central Asia Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 17.6 Central Asia Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 18 : Oceania Organs-on-chips Market Breakdown by Country, Type & Application
- 18.1 Oceania Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 18.2.1 Microfluidic Systems
- 18.2.2 Lab-on-a-chip
-
18.3 Oceania Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 18.3.1 Biomedical Research
- 18.3.2 Drug Development
- 18.3.3 Disease Modeling
- 18.4 Oceania Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 18.5 Oceania Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 18.6 Oceania Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 19 : MEA Organs-on-chips Market Breakdown by Country, Type & Application
- 19.1 MEA Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 19.2.1 Microfluidic Systems
- 19.2.2 Lab-on-a-chip
-
19.3 MEA Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 19.3.1 Biomedical Research
- 19.3.2 Drug Development
- 19.3.3 Disease Modeling
- 19.4 MEA Organs-on-chips Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 19.5 MEA Organs-on-chips Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 19.6 MEA Organs-on-chips Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Organs-on-chips market is expected to see value worth 1.5 Billion in 2019.
According to the report,the Organs-on-chips Industry size is projected to reach 5 Billion, exhibiting a CAGR of 30% by 2030.
The changing dynamics and trends such as Use Of AI To Enhance Predictive Accuracy, Integration With Other Research Technologies Like CRISPR are seen as major Game Changer in Global Organs-on-chips Market.
- Expansion Of Drug Testing And Development
- Opportunities In Personalized Healthcare Solutions
As Industry players prepare to scale up, Organs-on-chips Market sees major concern such as Ethical Concerns, High Development Costs, Need For Industry Standardization.
The market opportunity is clear from the flow of investment into Global Organs-on-chips Market, some of them are Expansion Of Drug Testing And Development, Opportunities In Personalized Healthcare Solutions.
Emulate, TissUse, AxoGen, CN Bio Innovations, Organovo, Mimetas, 3D Biotek, StemoniX, MIMETAS, Nortis, Biowire, Hesperos, 8D Technologies, Pioneering Technology, Prellis Biologics, Ncardia, Synlogic, BioTissue, InSphero, GlycoBio are the major operating companies profiled in Organs-on-chips market study.
Research paper of Global Organs-on-chips Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Biomedical Research, Drug Development, Disease Modeling.
The Global Organs-on-chips Market Study is segmented by Microfluidic Systems, Lab-on-a-chip.
The Global Organs-on-chips Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2024 - Base year: 2019. Forecast period**: 2025 to 2030 [** unless otherwise stated]
Lab models that mimic human organs using microfluidic systems for testing drugs, researching diseases, and understanding human physiology.
